These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19737144

  • 1. The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours.
    Yang H, Cho NH, Seong SY.
    Clin Exp Immunol; 2009 Nov; 158(2):174-85. PubMed ID: 19737144
    [Abstract] [Full Text] [Related]

  • 2. Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli.
    Bae MY, Cho NH, Seong SY.
    Clin Exp Immunol; 2009 Jul; 157(1):128-38. PubMed ID: 19659778
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.
    Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, Mukherjee P, Gendler SJ, Kufe D, Gong J.
    Immunology; 2003 Jun; 109(2):300-7. PubMed ID: 12757626
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N, Esparon S, Pouniotis D, Pietersz GA.
    Molecules; 2015 Aug 03; 20(8):14033-50. PubMed ID: 26247926
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection.
    Soares MM, Mehta V, Finn OJ.
    J Immunol; 2001 Jun 01; 166(11):6555-63. PubMed ID: 11359807
    [Abstract] [Full Text] [Related]

  • 11. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.
    Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ.
    J Immunother; 2003 Jun 01; 26(1):47-62. PubMed ID: 12514429
    [Abstract] [Full Text] [Related]

  • 12. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.
    Lakshminarayanan V, Thompson P, Wolfert MA, Buskas T, Bradley JM, Pathangey LB, Madsen CS, Cohen PA, Gendler SJ, Boons GJ.
    Proc Natl Acad Sci U S A; 2012 Jan 03; 109(1):261-6. PubMed ID: 22171012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice.
    Pinkhasov J, Alvarez ML, Rigano MM, Piensook K, Larios D, Pabst M, Grass J, Mukherjee P, Gendler SJ, Walmsley AM, Mason HS.
    Plant Biotechnol J; 2011 Dec 03; 9(9):991-1001. PubMed ID: 21740504
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA.
    Koido S, Kashiwaba M, Chen D, Gendler S, Kufe D, Gong J.
    J Immunol; 2000 Nov 15; 165(10):5713-9. PubMed ID: 11067929
    [Abstract] [Full Text] [Related]

  • 17. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR, Coleman J, Burchell JM, Taylor-Papadimitriou J, Noll T.
    Cell Immunol; 2004 Nov 15; 231(1-2):112-25. PubMed ID: 15919376
    [Abstract] [Full Text] [Related]

  • 18. Tecemotide: an antigen-specific cancer immunotherapy.
    Wurz GT, Kao CJ, Wolf M, DeGregorio MW.
    Hum Vaccin Immunother; 2014 Nov 15; 10(11):3383-93. PubMed ID: 25483673
    [Abstract] [Full Text] [Related]

  • 19. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
    Tanaka Y, Koido S, Ohana M, Liu C, Gong J.
    J Immunol; 2005 Feb 01; 174(3):1274-80. PubMed ID: 15661883
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-Mediated MUC1 gene transduction into human blood-derived dendritic cells.
    Maruyama K, Akiyama Y, Nara-Ashizawa N, Hojo T, Cheng JY, Mizuguchi H, Hayakawa T, Yamaguchi K.
    J Immunother; 2001 Feb 01; 24(4):345-53. PubMed ID: 11565836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.